[Pendahuluan - Kejang pascaoperasi merupakan salah satu komplikasi pascakraniotomi
tumor. Prevalensinya antara 4 – 20%, dan paling banyak muncul satu
minggu pascaoperasi. Penambahan obat fenitoin pada pemberian obat
levetiracetam untuk mengendalikan kejang pascaoperasi belum pernah ditelilti.
Tujuan - Untuk mengetahui apakah terdapat perbedaan antara kelompok yang
mendapatkan levetiracetam dengan dan tanpa penambahan fenitoin dalam hal
kejadian kejang pascaoperasi, efek samping, peningkatan dosis steroid, serta
gambaran faktor risiko kejang pascaoperasi. Metode - Penelitian ini merupakan
penelitian pendahuluan menggunakan metode uji klinis. Pasien dirandomisasi dan
dikelompokkan menjadi kelompok yang mendapatkan levetiracetam saja dan
levetiracetam dengan fenitoin. Diobervasi selama 7 hari pascaoperasi, apakah
terdapat kejang, efek samping, dan peningkatan dosis steroid. Pada kelompok
yang mendapatkan fenitoin, kadar fenitoin dalam darah diukur pada hari ke-7.
Hasil - Manfaat penambahan fenitoin pada pemberian levetiracetam masih belum
bisa dinilai karena jumlah sampel masih sedikit. Efek samping lebih banyak
ditemukan pada kelompok yang mendapatkan penambahan fenitoin.;Introduction – Postoperative seizure is one of complications of brain tumor
surgery. Prevalence is 4-20% and mostly occurred in the first postoperative week.
The beneficial of giving add on phenytoin to levetiracetam has never been studied
before. Aims – To determine the difference of postoperative seizure incidence,
side effect, elevation of steroid dose, and risk factors profile in both groups, the
levetiracetam group and levetiracetam with add on phenytoin group. Methods –
This is a pilot study with clinical trial design. Patients were randomized and
allocated into two groups, levetiracetam group and levetiracetam with add on
phenytoin group. Observation was done in 7 postoperative days. Any incidence of
postoperative seizures, drug side effects, and elevation of steroid dose was noted.
In group receiving phenyotin, the blood level of phenytoin was measured on the
7th day. Result – The benefit of add on phenytoin to levetiracetam therapy for
postoperative seizure in brain tumor patients could not be evaluated due to small
sample size. More drug related side effects were found on group receiving
phenytoin., Introduction – Postoperative seizure is one of complications of brain tumor
surgery. Prevalence is 4-20% and mostly occurred in the first postoperative week.
The beneficial of giving add on phenytoin to levetiracetam has never been studied
before. Aims – To determine the difference of postoperative seizure incidence,
side effect, elevation of steroid dose, and risk factors profile in both groups, the
levetiracetam group and levetiracetam with add on phenytoin group. Methods –
This is a pilot study with clinical trial design. Patients were randomized and
allocated into two groups, levetiracetam group and levetiracetam with add on
phenytoin group. Observation was done in 7 postoperative days. Any incidence of
postoperative seizures, drug side effects, and elevation of steroid dose was noted.
In group receiving phenyotin, the blood level of phenytoin was measured on the
7th day. Result – The benefit of add on phenytoin to levetiracetam therapy for
postoperative seizure in brain tumor patients could not be evaluated due to small
sample size. More drug related side effects were found on group receiving
phenytoin.]